REGN: Regeneron Pharmaceuticals, Inc. Stock

by  •  • Comments Off on REGN: Regeneron Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 51,968.31
Enterprise Value ($M) 36,327.41
Book Value ($M) 29,387.60
Book Value / Share 277.50
Price / Book 1.77
NCAV ($M) 18,221.50
NCAV / Share 172.06
Price / NCAV 2.85

Profitability (mra)
Return on Invested Capital (ROIC) 0.14
Return on Assets (ROA) 0.13
Return on Equity (ROE) 0.17

Liquidity (mrq)
Quick Ratio 5.02
Current Ratio 5.71

Balance Sheet (mrq) ($M)
Current Assets 26,379.10
Assets 37,545.20
Liabilities 8,157.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 14,202.00
Operating Income 4,227.20
Net Income 4,412.60
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 4,420.50
Cash from Investing -2,468.10
Cash from Financing -2,200.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-22 13G/A Jpmorgan Chase & Co 5.10 -23.17
02-12 13G/A Fmr Llc 7.60 -20.63

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-02 314,440 2,607,669 12.06
2025-05-30 1,043,452 5,722,255 18.23
2025-05-29 191,588 644,497 29.73
2025-05-28 225,846 802,870 28.13

(click for more detail)

Similar Companies
QURE – uniQure N.V. RARE – Ultragenyx Pharmaceutical Inc.
RDUS – Radius Recycling, Inc. REPL – Replimune Group, Inc.
RGEN – Repligen Corporation


Financial data and stock pages provided by
Fintel.io